[Physiopathological bases of therapy influencing noradrenergic transmission in ischemic cerebral accidents].
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D002544:Cerebral Infarction / Q000188:drug therapy; D003000:Clonidine / Q000627:therapeutic use; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism*; D011433:Propranolol / Q000627:therapeutic use; D012701:Serotonin / Q000097:blood; D014365:Tryptophan Hydroxylase / Q000097:blood
D000959:Antihypertensive Agents; D002395:Catecholamines; D012701:Serotonin; D011433:Propranolol; D014365:Tryptophan Hydroxylase; D003000:Clonidine; D009638:Norepinephrine
Bazele fiziopatologice ale terapiei cu impact asupra transmisiei noradrenergice în accidentele ischemice cerebrale.